Psoriasis patients exhibited lower serum adiponectin levels relative to the healthy controls (Shibata et al., 2009; Oh et al., 2014), indicating that adiponectin’s supposedly anti-inflammatory role is downregulated in psoriasis. Here, ADIPOQ is linked to psoriasis.